Search research articles
Contact Us
Filters
Showing results (261-270 of 358) with videos related to
Page
of 36
Sort By:
Psychological Medicine
|
December 16, 2021
Familial clustering of psychiatric disorders and low IQ
Mark Weiser, Or Frenkel, Daphna Fenchel, et al.
Schizophrenia Research
|
August 4, 2019
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial
Jonathan Rabinowitz, Stefan Badescu, Pavel Palamarchuk, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 11, 2020
Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort
Linda Levi, Mor Bar Haim, Shimon Burshtein, et al.
Frontiers in Oncology
|
March 15, 2021
Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer
Karen M Gallegos, Jankiben R Patel, Shawn D Llopis, et al.
Schizophrenia Bulletin
|
January 22, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials
Mark Weiser, Daisy Zamora, Linda Levi, et al.
Biomolecules
|
April 23, 2022
A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells
Jankiben R Patel, Prasad Thangavelu, Renee M Terrell, et al.
The American Journal of Psychiatry
|
July 29, 2017
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia
Michael Davidson, Jay Saoud, Corinne Staner, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 2, 2007
Social and cognitive functioning, urbanicity and risk for schizophrenia
Mark Weiser, Jim van Os, Abraham Reichenberg, et al.
The American Journal of Cardiology
|
July 7, 2009
Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease
Darbie Maccubbin, Michael J Koren, Michael Davidson, et al.
Cancer Chemotherapy and Pharmacology
|
December 27, 2015
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
Rajiv Kumar, Shir Kiong Lu, Anna Minchom, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 358) with videos related to
Sort By:
Page
of 36
Psychological Medicine
|
December 16, 2021
Familial clustering of psychiatric disorders and low IQ
Mark Weiser, Or Frenkel, Daphna Fenchel, et al.
Schizophrenia Research
|
August 4, 2019
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial
Jonathan Rabinowitz, Stefan Badescu, Pavel Palamarchuk, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 11, 2020
Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort
Linda Levi, Mor Bar Haim, Shimon Burshtein, et al.
Frontiers in Oncology
|
March 15, 2021
Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer
Karen M Gallegos, Jankiben R Patel, Shawn D Llopis, et al.
Schizophrenia Bulletin
|
January 22, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials
Mark Weiser, Daisy Zamora, Linda Levi, et al.
Biomolecules
|
April 23, 2022
A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells
Jankiben R Patel, Prasad Thangavelu, Renee M Terrell, et al.
The American Journal of Psychiatry
|
July 29, 2017
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia
Michael Davidson, Jay Saoud, Corinne Staner, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 2, 2007
Social and cognitive functioning, urbanicity and risk for schizophrenia
Mark Weiser, Jim van Os, Abraham Reichenberg, et al.
The American Journal of Cardiology
|
July 7, 2009
Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease
Darbie Maccubbin, Michael J Koren, Michael Davidson, et al.
Cancer Chemotherapy and Pharmacology
|
December 27, 2015
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
Rajiv Kumar, Shir Kiong Lu, Anna Minchom, et al.
Page
of 36